Vol 2021, No 3 (2021)

Table of Contents

Research & Development

Lilly Partners with Rigel on RIPK1 Inhibitors Abstract pdf html
Michelle Liu

Licensing

Boston Pharmaceuticals In-Licenses Another Two Programmes from GSK Abstract pdf html
Michelle Liu

Mergers & Acquisitions

Merck & Co. Hands Over US$1.85 B to Acquire Pandion Therapeutics Abstract pdf html
Michelle Liu
Takeda Continues Divestment Spree with US$1.3 B Teijin Pharma Deal to Reduce Debt Abstract pdf html
Michelle Liu
Amgen Spends US$1.9 B on Five Prime to Boost Cancer Pipeline Abstract pdf html
Michelle Liu
Jazz Pharmaceuticals Bets on Cannabis-based Medicines with US$7.2 B GW Pharmaceuticals Buy Abstract pdf html
Neha Madhwani & Michelle Liu

Opinion & Analysis

IQVIA Pharma Deals Review of 2020 Abstract pdf
Heather Cartwright, Michelle Liu & Taskin Ahmed


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.